Use of narcotic analgesics in the emergency department treatment of migraine headache

Neurology

Volumn 62, Issue 10, 2004, Pages 1695-1700

  Colman, I ^a   Rothney, A ^b   Wright, S C ^b   Zilkalns, B ^b   Rowe, B H ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DIHYDROERGOTAMINE; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; PROCHLORPERAZINE; SUMATRIPTAN;

ADULT; CANADA; CONTROLLED STUDY; DISEASE DURATION; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PHOTOPHOBIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; VOMITING;

EID: 2442662794     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000127304.91605.BA     Document Type: Review

References (25)

1. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994;44:S17-S23.
2. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 1993;20:131-137.
3. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics 1992;2:67-76.
4. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999;159:813-818.
5. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-762.
6. Moore KL, Noble SL. Drug treatment of migraine: part I. Acute therapy and drug-rebound headache. Am Fam Physician 1997;56:2039-2034.
7. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. Can Med Assoc J 1997;156:1273-1287.
8. Gallai V, Sarchielli P. Diagnostic and therapeutic guidelines for migraine: Italian Society for the Study of Headaches. J Headache Pain 2001;2:S125-S129.
9. Vinson DR. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med 2002;39:215-222.
10. Statistics Canada - population of census metropolitan areas (http:// www.statcan.ca/english/Pgdb/demo05.htm); accessed October 25, 2003.
11. International classification of diseases. 9th rev: clinical modification. Washington, DC: Public Health Service, US Department of Health and Human Services; 1988.
12. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley, 2000.
13. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-298.
14. Vinson DR, Hurtado TR, Vandenberg JT, Banwart L. Variations among emergency departments in the treatment of benign headache. Ann Emerg Med 2003;41:90-97.
15. Larkin GL, Prescott JE. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med 1992;21:919-924.
16. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology 1989;39:590-592.
17. Carleton SC, Shesser RF, Pietrzak MP, et al. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med 1998;32:129-138.
18. Klapper JA, Stanton J. Current emergency treatment of severe migraine headaches. Headache 1993;33:560-562.
19. Scherl ER, Wilson JF. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 1995;35:256-259.
20. Duarte C, Dunaway F, Turner L, Aldag J, Frederick R. Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial. Ann Emerg Med 1992;21:1116-1121.
21. Lane PL, McLellan BA, Baggoley CJ. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 1989;18:360-365.
22. Stiell IG, Dufour DG, Moher D, Yen M, Beilby WJ, Smith NA. Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial. Ann Emerg Med 1991;20:1201-1205.
23. Langemark M, Olesen J. Drug abuse in migraine patients. Pain 1984;19:81-86.
24. Salomone JA, Thomas RW, Althoff JR, Watson WA. An evaluation of the role of the ED in the management of migraine headaches. Am J Emerg Med 1994;12:134-137.
25. Tennant FS Jr, Rawson RA. Outpatient treatment of prescription opioid dependence: comparison of two methods. Arch Intern Med 1982;142:1845-1847.